Results 1 to 10 of about 6,701,012 (264)

Hormone replacement therapy [PDF]

open access: yesBMJ, 2012
Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core   +6 more sources

Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy

open access: yesAmerican Journal of Nephrology, 2021
Background: The global epidemiology of end-stage kidney disease (ESKD) reflects each nation’s unique genetic, environmental, lifestyle, and sociodemographic characteristics.
J. Thurlow   +6 more
semanticscholar   +1 more source

mRNA in the Context of Protein Replacement Therapy

open access: yesPharmaceutics, 2023
Protein replacement therapy is an umbrella term used for medical treatments that aim to substitute or replenish specific protein deficiencies that result either from the protein being absent or non-functional due to mutations in affected patients ...
Theofanis Vavilis   +6 more
semanticscholar   +1 more source

Guidelines for surfactant replacement therapy in neonates.

open access: yesPaediatrics & child health, 2021
Surfactant replacement therapy (SRT) plays a pivotal role in the management of neonates with respiratory distress syndrome (RDS) because it improves survival and reduces respiratory morbidities.
E. Ng, V. Shah
semanticscholar   +1 more source

Development of an mRNA replacement therapy for phenylketonuria

open access: yesMolecular Therapy: Nucleic Acids, 2022
Phenylketonuria (PKU) is an inborn error caused by deficiencies in phenylalanine (Phe) metabolism. Mutations in the phenylalanine hydroxylase (PAH) gene are the main cause of the disease whose signature hallmarks of toxically elevated levels of Phe ...
C. G. Perez-Garcia   +11 more
semanticscholar   +1 more source

Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration

open access: yesMedicina, 2021
Background and objectives: At present, there is insufficient evidence to support the use of continuous veno-venous haemofiltration (CVVH) in the early treatment of septic shock.
Georgijs Moisejevs   +12 more
doaj   +1 more source

Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.

open access: yesNew England Journal of Medicine, 2020
Background Acute kidney injury is common in critically ill patients, many of whom receive renal-replacement therapy. However, the most effective timing for the initiation of such therapy remains uncertain. Methods We conducted a multinational, randomized,
Starrt-Aki Investigators   +33 more
semanticscholar   +1 more source

The association of kidney stress test with water salt loading with estimated glomerular filtration rate decline in patients with chronic kidney disease stage 1-3 [PDF]

open access: yesArchives of the Balkan Medical Union, 2019
Introduction. Kidney Disease Outcomes Quality Initiative (KDIGO) Group proposes the estimated glomerular filtration rate (eGFR) and albuminuria rate for a combined risk of clinical outcomes in patients with chronic kidney disease (CKD).
Dmytro IVANOV   +2 more
doaj   +1 more source

Publisher Correction to: Renal Replacement Therapy, volume 5

open access: yesRenal Replacement Therapy, 2019
An error occurred during the publication of a number of articles in Renal Replacement Therapy. Several articles were published in volume 5 with a duplicate citation number.
Renal Replacement Therapy
doaj   +1 more source

Peritonitis-induced peritoneal injury models for research in peritoneal dialysis review of infectious and non-infectious models

open access: yesRenal Replacement Therapy, 2017
Peritonitis is an important complication of peritoneal dialysis. Several animal peritonitis models have been described, including bacterial and fungal models that are useful for studying inflammation in peritonitis. However, these models have limitations
Yasuhiko Ito   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy